Transduction of human T cells with a novel T-cell receptor confers anti-HCV reactivity.
Hepatitis C Virus (HCV) is a major public health concern, with no effective vaccines currently available and 3% of the world's population being infected. Despite the existence of both B- and T-cell immunity in HCV-infected patients, chronic viral infection and HCV-related malignancies progress....
Saved in:
| Main Authors: | Yi Zhang, Yeuying Liu, Kelly M Moxley, Lucy Golden-Mason, Michael G Hughes, Tongxin Liu, Mirjam H M Heemskerk, Hugo R Rosen, Michael I Nishimura |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2010-07-01
|
| Series: | PLoS Pathogens |
| Online Access: | https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1001018&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimizing T cell transduction: a novel transduction device for efficient and scalable gene delivery
by: Kang-Zheng Lee, et al.
Published: (2025-08-01) -
HCV Infection and B-Cell Lymphomagenesis
by: Masahiko Ito, et al.
Published: (2011-01-01) -
Risk of HBV reactivation in HBV/HCV-co-infected HCV-treated patients: A single-center study
by: Young Joo Park, et al.
Published: (2025-01-01) -
AAVR Expression is Essential for AAV Vector Transduction in Sensory Hair Cells
by: Fan Wu, et al.
Published: (2025-08-01) -
Forward Programming of Cardiac Stem Cells by Homogeneous Transduction with MYOCD plus TBX5.
by: Elisa Belian, et al.
Published: (2015-01-01)